Concepedia

Author

Julia Origüen

Hospital Universitario 12 De OctubreORCID

Also Known As

Adriana Hristea, J Origüen, J. Origuen, J. Origüen, Julia Origen, Julia Origuen, Julia Origüen, Julia Origȕen, Maria Angeles Orellana, María Ángeles Orellana

43

Publications

1.9K

Citations

20

H-Index

33

Concepts

All Affiliations

Hospital Universitario 12 De OctubreResearch Institute Hospital 12 de OctubreHospital Universitario Ramón y CajalVall d'Hebron Hospital UniversitariHospital Universitario La Paz
JO

About

Julia Origüen is an author at Hospital Universitario 12 De Octubre specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

1.1K

2

Epidemiology

5

5

837

3

Health Sciences

2

2

160

4

Public Health

2

2

562

5

Immunology

1

1

16

Julia Origüen

×

26

Publications

1.6K

Citations

17

H-Index

YearCitations

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto,

The Lancet Infectious Diseases

2017

511

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Salvador Pérez-Galera, Elena Salamanca,

Antimicrobial Agents and Chemotherapy

2016

150

Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial

Julia Origüen, Francisco López‐Medrano, Mario Fernández‐Ruiz,

American Journal of Transplantation

2016

127

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto,

Mayo Clinic Proceedings

2016

115

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-<b>β</b>-lactamase-producing Enterobacteriaceae

Zaira R. Palacios‐Baena, Belén Gutiérrez‐Gutiérrez, Marina de Cueto,

Journal of Antimicrobial Chemotherapy

2016

62

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing <i>Escherichia coli</i> and ESBL-Producing <i>Klebsiella pneumoniae</i>

Oded Scheuerman, Vered Schechner, Yehuda Carmeli,

Infection Control and Hospital Epidemiology

2018

62

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

Patricia Muñóz, Antonio Vena, Marina Machado,

Journal of Antimicrobial Chemotherapy

2018

59

Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study

Mario Fernández‐Ruiz, Francisco López‐Medrano, María Asunción Pérez‐Jacoiste Asín,

Journal of Medical Virology

2020

53

Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options

Julia Origüen, Mario Fernández‐Ruiz, Francisco López‐Medrano,

Transplant Infectious Disease

2016

51

Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study

Núria Fernández-Hidalgo, Aída Ribera, Nieves Larrosa,

Clinical Microbiology and Infection

2017

51

Page 1